[HTML][HTML] IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
YJ Chen, SN Luo, H Wu, NP Zhang, L Dong… - Journal of Translational …, 2022 - Springer
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
[HTML][HTML] IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
YJ Chen, SN Luo, H Wu, NP Zhang… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
C Yan-Jie, SN Luo, H Wu, Z Ning-Ping… - Journal of …, 2022 - search.proquest.com
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
IRF-2 Inhibits Cancer Proliferation by Promoting AMER1 Transcription in Human Gastric Cancer
Y Chen, S Luo, H Wu, N Zhang, L Dong, T Liu, L Liang… - 2021 - researchsquare.com
Abstract Interferon regulatory factor 2 (IRF-2) plays the roles of an anti-oncogene in gastric
cancer (GC). However, the mechanism remains unknow. The expression of IRF-2 in GC …
cancer (GC). However, the mechanism remains unknow. The expression of IRF-2 in GC …
[HTML][HTML] IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
YJ Chen, SN Luo, H Wu… - Journal of …, 2022 - … -medicine.biomedcentral.com
Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer (GC);
however, the underlying mechanism remains unknown. This study determined the …
however, the underlying mechanism remains unknown. This study determined the …
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer.
YJ Chen, SN Luo, H Wu, NP Zhang, L Dong… - Journal of …, 2022 - europepmc.org
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer.
YJ Chen, SN Luo, H Wu, NP Zhang, L Dong… - Journal of …, 2022 - go.gale.com
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
YJ Chen, SN Luo, H Wu, NP Zhang… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …
(GC); however, the underlying mechanism remains unknown. Methods This study …
[PDF][PDF] IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer
YJ Chen, SN Luo, H Wu, NP Zhang, L Dong… - 2022 - … -medicine.biomedcentral.com
Background: Interferon regulatory factor 2 (IRF‑2) acts as an anti‑oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods: This study …
(GC); however, the underlying mechanism remains unknown. Methods: This study …
IRF-2 Inhibits Cancer Proliferation by Promoting AMER1 Transcription in Human Gastric Cancer
Y Chen, S Luo, H Wu, N Zhang, L Dong, T Liu, L Liang… - 2021 - europepmc.org
Interferon regulatory factor 2 (IRF-2) plays the roles of an anti-oncogene in gastric cancer
(GC). However, the mechanism remains unknow. The expression of IRF-2 in GC tissues and …
(GC). However, the mechanism remains unknow. The expression of IRF-2 in GC tissues and …